Target intelligence / Profile preview

Replication protein A2 pseudogene 1 (RPA2P1)

Target
RPA2P1
Molecular classification
Pseudogene, Other (not an enzyme, transporter, receptor, etc.)
01

Overview

Replication protein A2 pseudogene 1 (RPA2P1) is a non-functional DNA sequence that closely resembles the gene encoding Replication protein A2 (RPA2), a subunit of the replication protein A complex involved in DNA replication and repair[1][2]. As a pseudogene, RPA2P1 has lost the ability to produce a functional protein due to mutations or lack of essential regulatory elements[4]. There is no evidence for direct involvement in cellular pathways or diseases, nor is it used as a marker or therapeutic target. Like other pseudogenes, it may hypothetically participate in gene regulation (e.g., as miRNA decoys, sources of noncoding RNA, or gene conversion events), but there are no data indicating that RPA2P1 itself plays any such regulatory or pathogenic roles[4]. Key clarifications: - RPA2P1 is a *pseudogene*, not a therapeutically actionable target. - If you sought information about the functional protein (Replication protein A2), refer instead to "Replication protein A2 (RPA2)," which is involved in DNA replication and repair—a critical enzyme in genomic maintenance[1][2]. Summary: RPA2P1 (Replication protein A2 pseudogene 1) is not a functional target, not involved in therapeutic or pathological mechanisms, and not considered a receptor, enzyme, transporter, or similar class of molecule. Any interest in DNA replication or repair should be redirected to the functional gene *RPA2* and its protein product RPA2[1][2].

02

Mechanism of action

Not applicable; RPA2P1 does not act as a molecular target.

03

Biological functions

As a pseudogene, RPA2P1 does not encode a functional protein and has no direct biological function, though pseudogenes as a class may participate in gene regulation via noncoding RNA mechanisms such as miRNA decoys or siRNA generation[4].
04

Disease associations

None directly attributed; pseudogenes as a class may play regulatory roles in cancer and other diseases, but there is no evidence that RPA2P1 itself is implicated in disease[4].

Beyond the preview

Go deeper on Replication protein A2 pseudogene 1 (RPA2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Replication protein A2 pseudogene 1 (RPA2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call